These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
516 related items for PubMed ID: 9158701
21. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. Gläsker S, Bender BU, Apel TW, Natt E, van Velthoven V, Scheremet R, Zentner J, Neumann HP. J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493 [Abstract] [Full Text] [Related]
22. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity. Gijtenbeek JM, Jacobs B, Sprenger SH, Eleveld MJ, van Kessel AG, Kros JM, Sciot R, van Calenbergh F, Wesseling P, Jeuken JW. J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390 [Abstract] [Full Text] [Related]
24. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH. Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720 [Abstract] [Full Text] [Related]
25. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease. Liang X, Shen D, Huang Y, Yin C, Bojanowski CM, Zhuang Z, Chan CC. Ophthalmology; 2007 Jan 16; 114(1):147-56. PubMed ID: 17070589 [Abstract] [Full Text] [Related]
29. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M. Cancer Res; 1994 Sep 15; 54(18):4845-7. PubMed ID: 8069849 [Abstract] [Full Text] [Related]
32. An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Webster AR, Richards FM, MacRonald FE, Moore AT, Maher ER. Am J Hum Genet; 1998 Oct 15; 63(4):1025-35. PubMed ID: 9758595 [Abstract] [Full Text] [Related]
34. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study. Dollfus H, Massin P, Taupin P, Nemeth C, Amara S, Giraud S, Béroud C, Dureau P, Gaudric A, Landais P, Richard S. Invest Ophthalmol Vis Sci; 2002 Sep 15; 43(9):3067-74. PubMed ID: 12202531 [Abstract] [Full Text] [Related]
35. Von Hippel-Lindau syndrome. A pleomorphic condition. Friedrich CA. Cancer; 1999 Dec 01; 86(11 Suppl):2478-82. PubMed ID: 10630173 [Abstract] [Full Text] [Related]
36. [Von Hippel-Lindau syndrome with spinal, cerebellar, and retinal hemangioblastoma in identical twins]. Wessels T, Kemeny S, Block F. Nervenarzt; 2002 Dec 01; 73(12):1195-8. PubMed ID: 12486572 [Abstract] [Full Text] [Related]
38. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER. Cancer Res; 2002 Jul 01; 62(13):3803-11. PubMed ID: 12097293 [Abstract] [Full Text] [Related]
40. Hemangioblastomas of the retina: impact of von Hippel-Lindau disease. Niemelä M, Lemeta S, Sainio M, Rauma S, Pukkala E, Kere J, Böhling T, Laatikainen L, Jääskeläinen J, Summanen P. Invest Ophthalmol Vis Sci; 2000 Jun 01; 41(7):1909-15. PubMed ID: 10845616 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]